Risk of Fractures Associated with Dipeptidyl Peptidase-4 Inhibitor Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
出版年份 2019 全文链接
标题
Risk of Fractures Associated with Dipeptidyl Peptidase-4 Inhibitor Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
作者
关键词
Dipeptidyl peptidase-4 inhibitors, Fracture, Meta-analysis, Type 2 diabetes mellitus
出版物
Diabetes Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-26
DOI
10.1007/s13300-019-0668-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials
- (2018) Y. S. Zhang et al. OSTEOPOROSIS INTERNATIONAL
- Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia
- (2017) Mikkel B Christensen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies
- (2017) Mohammad Adil et al. Pharmacological Reports
- Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis
- (2017) Eladio Losada-Grande et al. Scientific Reports
- Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption
- (2016) Guillaume Mabilleau et al. BONE
- Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
- (2016) Deborah E. Sellmeyer et al. DIABETES
- Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial
- (2016) Robert G. Josse et al. DIABETES OBESITY & METABOLISM
- DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes – A systematic review and meta-analysis
- (2016) Jil Mamza et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk of fractures and diabetes medications: a nationwide cohort study
- (2016) H. J. Choi et al. OSTEOPOROSIS INTERNATIONAL
- Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus
- (2015) Xiao-Wu Chen et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review
- (2015) A. Palermo et al. OSTEOPOROSIS INTERNATIONAL
- Reporting Quality of Systematic Reviews and Meta-Analyses of Otorhinolaryngologic Articles Based on the PRISMA Statement
- (2015) Jeroen P. M. Peters et al. PLoS One
- DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats
- (2014) Lorenzo Glorie et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
- (2014) Johanna H.M. Driessen et al. BONE
- Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin
- (2014) Itamar Raz et al. DIABETES CARE
- Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality
- (2013) Aleksandra Mieczkowska et al. BONE
- Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus
- (2013) Boaz Hirshberg et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor
- (2013) Guillaume Mabilleau et al. JOURNAL OF ENDOCRINOLOGY
- Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials (胰高血糖素样肽-1受体激动剂的使用与骨折的关系：一项对随机临床试验的meta分析)
- (2013) Guillaume Mabilleau et al. Journal of Diabetes
- Bone, sweet bone—osteoporotic fractures in diabetes mellitus
- (2012) Christine Hamann et al. Nature Reviews Endocrinology
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- Grading quality of evidence and strength of recommendations in clinical practice guidelines
- (2009) J. L. Brożek et al. ALLERGY
- Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states
- (2009) Bernardo Nuche-Berenguer et al. REGULATORY PEPTIDES
- Use of Thiazolidinediones and Fracture Risk
- (2008) Christian Meier et al. ARCHIVES OF INTERNAL MEDICINE
- The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption
- (2007) Chizumi Yamada et al. ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started